Target intelligence / Profile preview

Yersinia pestis antigens

Molecular classification
Bacterial capsular protein, Adhesin, Nonpilus organelle protein, Bacterial outer membrane protein, Virulence factor, Fimbrial (fimbriae protein)
01

Overview

Yersinia pestis antigens commonly refer to the principal virulence factors used by the bacterium to evade host defenses, adhere to host cells, or inject cytotoxic proteins via the type III secretion system. The F1 capsular antigen (Caf1) forms a protective polymeric capsule that inhibits phagocytosis, playing a major role in the bacterium’s ability to evade the immune system and acting as a key target for vaccine and diagnostic strategies[2][6][7][9]. The V antigen (LcrV) is a multifunctional outer membrane protein critical for regulating the Yop type III secretion system and modulating host immune responses, also serving as a vaccine antigen[1][5]. The pH 6 antigen (PsaA) is a fimbrial adhesin involved in specific attachment to mammalian cells and has a documented role in virulence[3]. Together, these antigens serve as diagnostic markers, vaccine targets, and models for studying bacterial pathogenicity. However, "Yersinia pestis antigens" as a collective term is not a singular, well-defined molecular target; accurate scientific discourse requires referring to individual antigens by their canonical names.

Other names
F1 antigenV antigenLcrVCaf1pH 6 antigenPsaA
02

Mechanism of action

F1 and LcrV serve as subunit vaccine components, inducing protective antibodies that block bacterial immune evasion and facilitate clearance

03

Biological functions

Immune evasionAdhesion to host cellsRegulation of type III secretion systemVirulence/disease establishment
04

Disease associations

Infection (plague: bubonic, pneumonic)Immune evasion/pathogenicity
05

Safety considerations

Antigenic variability and potential for immune escapeFor vaccines: immunogenicity in different populations, possible hypersensitivity
06

Interacting drugs

Vaccines and experimental monoclonal antibodies targeting F1 and/or V antigens
07

Biomarkers

Anti-F1 IgG and anti-LcrV IgG (for plague exposure or vaccine response)

Beyond the preview

Go deeper on Yersinia pestis antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yersinia pestis antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call